ESC 365 - Intravascular administration of soluble Sars-CoV-2 Spike protein triggers non-infective heart and lung inflammation and vascular pericytes rarefaction in healthy mice.

ESC Professional Premium Access

Intravascular administration of soluble Sars-CoV-2 Spike protein triggers non-infective heart and lung inflammation and vascular pericytes rarefaction in healthy mice.

Session: Basic and Translational Late-Breaking Science 1

Topic: Microcirculation, Angiogenesis, Arteriogenesis

Speaker: Doctor E. Avolio (Bristol, GB)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Elisa Avolio

University of Bristol, Bristol (United Kingdom of Great Britain & Northern Ireland)

1 presentation

0 follower

3 more presentations in this session

CRISPR/Cas9 editing of CaMKII as a strategy for cardioprotection against ischemia/reperfusion injury.

Speaker: Professor S. Lebek (Regensburg, DE)

Is empagliflozin still cardioprotective in SGLT2 KO mice?

Speaker: Miss S. Chen (Amsterdam, NL)

Plasma of COVID-19 positive patients promote oxidative stress and proinflammatory responses in endothelial cells: Potential role of the pro-inflammatory cytokines/SGLT2 pathway.

Speaker: Doctor A. Mroueh (Strasbourg, FR)

Access the full session

Basic and Translational Late-Breaking Science 1

Speakers: Doctor E. Avolio, Professor S. Lebek, Miss S. Chen, Doctor A. Mroueh

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources